Previous Page  13 / 17 Next Page
Information
Show Menu
Previous Page 13 / 17 Next Page
Page Background

Page 50

Notes:

allied

academies

Journal of Medical Oncology & Therapeutics | Volume 4

March 18-19, 2019 | London, UK

Oncology & Cancer Therapy

International Conference on

Laparoscopic proximal gastrectomy in gastro esophageal junction tumors

Ihab Ahmed

Cairo University, Egypt

F

or Siewert type I and II gastroesophageal junction tumor

(GEJ) laparoscopic proximal gastrectomy can be performed. It

is associated with several perioperative benefits compared with

open proximal gastrectomy. The use of laparoscopic proximal

gastrectomy (LPG) has become an increasingly popular approach

for select tumors

Methods

: We describe our technique for LPG, including the

preoperative work-up, illustrated images of the main principle

steps of the surgery, and our postoperative course.

Results

: Thirteen pts (nine males, four female) with type I,

II (GEJ) adenocarcinoma had laparoscopic radical proximal

gastrectomy and D2 lymphadenectomy. All our patient received

neoadjuvant chemotherapy, eleven patients had intrathoracic

anastomosis through mini thoracotomy (two hand sewn end

to end anastomoses and the other 9 patient end to side using

circular stapler), two patients with intrathoracic anastomosis

had flap and wrap technique, two patients had thoracoscopic

esophageal andmediastinal lymph node dissection with cervical

anastomosis

The mean blood loss 80ml, no cases were converted to open.

The mean operative time 250 minute Average LN retrieved 19-

25, No sever complication such as leakage, stenosis, pancreatic

fistula,or intra-abdominal abscess were reported. Only One

patient presentedwith empyema 1.5month after discharge that

was managed conservatively.

Conclusion

: For carefully selected patients, LPG in GEJ tumour

type I nad II is a safe and reasonable alternative for open

technique, which is associated with similar oncologic outcomes

and low morbidity. It showed less blood loss, respiratory

infections, with similar 1- and 3-year survival rates.

e:

ihab.saad@nci.cu.edu.eg